title: Alterations in nitric oxide activity and sensitivity in early streptozotocin-induced diabetes depend on arteriolar size.
abstract: Changes in NO activity may play an important role in the early increase in microvascular flow that has been implicated in the pathogenesis of diabetic microangiopathy. We assessed, in the in situ spinotrapezius muscle preparation of 6 weeks' streptozotocin-diabetic rats (n = 6) and of age-matched controls (n = 8), basal inside diameters of A2-A4 arterioles and the reactivity to topically applied acetylcholine and nitroprusside, before and after N(G)-nitro-L-arginine. In diabetic rats, cholinergic vasodilatation in A2-A4 arterioles was intact. Basal diameter in A3 and A4 arterioles was significantly higher in streptozotocin-diabetic rats. The increased basal diameter in A3 arterioles was partially due to an increased contribution of NO to basal diameter. The response to nitroprusside was impaired in streptozotocin-diabetic rats in A2, but not in A3 and A4 arterioles. Thus, this study shows that NO activity and sensitivity are altered after 6 weeks of streptozotocin-induced diabetes. These streptozotocin-induced changes are anatomically specific and, for arterioles, depend on their position within the vascular tree.
authors.affiliation: Department of Internal Medicine, Institute for Cardiovascular Research, Vrije Universiteit, Amsterdam, The Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: van Dam
authors.forename: C
authors.initials: C
authors.lastname: Demirci
authors.forename: H J
authors.initials: HJ
authors.lastname: Reitsma
authors.forename: A A
authors.initials: AA
authors.lastname: van Lambalgen
authors.forename: G C
authors.initials: GC
authors.lastname: van den Bos
authors.forename: G J
authors.initials: GJ
authors.lastname: Tangelder
authors.forename: C D
authors.initials: CD
authors.lastname: Stehouwer
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D002302:Cardiac Output; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000503:physiopathology*; D006339:Heart Rate; D007328:Insulin / Q000097:blood; D008297:Male; D018715:Microscopy, Video; D018482:Muscle, Skeletal / Q000098:blood supply*; D009569:Nitric Oxide / Q000502:physiology*; D009599:Nitroprusside / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D013997:Time Factors; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D019323:omega-N-Methylarginine / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D007328:Insulin; D009599:Nitroprusside; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D000241:Adenosine; D000109:Acetylcholine